Latest Breaking News On - Clinical trial application - Page 1 : vimarsana.com

JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)

JJP Biologics has received a positive conclusion on the Clinical Trial Application assessment for a Phase I Study of a potential first-in-class anti-CD89 antagonist, JJP-1212 monoclonal antibody for

France
Germany
Rouen
Haute-normandie
Poland
Polish
Marjolein-van-egmond
Dawid-lyzwa
Pascal-joly
Pawel-szczepanski
European-union
European-medicines-agency

JJP Biologics Launches First Human Trial of Anti-Inflammatory MAb JJP-1212

JJP Biologics Launches First Human Trial of Anti-Inflammatory MAb JJP-1212
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Warsaw
L67
Poland
Polish
Marjolein-van-egmond
Vu-university-medical-center-amsterdam
European-medicines-agency
Clinical-trial-application
Phasei-study
Medical-center-amsterdam
Scientific-advisory-board
Management-board-member

JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89) - Iberonews

JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89) - Iberonews
iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.

Clinical-trial-application
Phasei-study

JJP Biologics Announces Positive Decision to Execute a FirstinHuman Clinical Trial of AntiInflammatory mAb JJP1212 antiCD89

JJP Biologics a private biopharmaceutical company developing innovative antibodybased therapies announces a positive decision issued by the European Medicines Agency on the Clinical Trial Application to conduct a phase I clinical study in healthy participants EudraCT 20235086613300 with their potential firstinclass antiCD89 antagonist JJP1212.

Rouen
Haute-normandie
France
Warsaw
L67
Poland
Germany
Polish
Pascal-joly
Marjolein-van-egmond
Research-agency
European-union

CDR-Life Inc.: CDR-Life Announces Initiation of CDR404 Phase 1 Trial for Treatment of Solid Tumors at ASCO

CDR-Life Inc. today announced the initiation of enrollment for the Phase 1 trial of CDR404, its lead program in development as a precision immunotherapy for solid tumors. CDR404 will be the focus of

Chicago
Illinois
United-states
Denmark
American
Lauren-arnold
Christian-leisner
American-society-of-clinical-oncology
Clinical-oncology
Annual-meeting
Investigational-new-drug
Clinical-trial-application

Evotec reports Q1 2024 results and provides corporate update

EQS-News: Evotec SE / Key word: Quarterly / Interim Statement Evotec reports Q1 2024 results and provides corporate update 22.05.2024 / 07:00 CET/CEST The issuer is...

Austria
France
Hamburg
Germany
Corbion
Basse-normandie
Worth-an-der-donau
Niederörreich
Mario-polywka
Gabriele-hansen
Christian-wojczewski
Volker-braun

EQS-News: Evotec reports Q1 2024 results and provides corporate update

EQS-News: EVOTEC SE / Key word(s): Quarterly / Interim Statement Evotec reports Q1 2024 results and provides corporate updat...

Austria
Corbion
Basse-normandie
France
Germany
Hamburg
Worth-an-der-donau
Niederörreich
Mario-polywka
Crohn-colitisfoundation
Hinnerk-rohwedder
Christian-wojczewski

Evotec Reports Q1 2024 Results and Provides Corporate Update

Evotec Reports Q1 2024 Results and Provides Corporate Update
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

France
Hamburg
Germany
Worth-an-der-donau
Niederörreich
Austria
Corbion
Basse-normandie
Mario-polywka
Hinnerk-rohwedder
Evotec-biologics
Christian-wojczewski

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
New-york
Philadelphia
Pennsylvania
Miami
Florida
Austria
Vienna
Wien
American
Anup-marda

PHAXIAM provides Business and Financial Update for the First Quarter of 2024

PHAXIAM provides Business and Financial Update for the First Quarter of 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Paris
France-general
France
Cambridge
Cambridgeshire
United-kingdom
French
Eric-soyer
Pharma-bio
Enregistrement-universel
Arthur-rouill
Euronext